Ignite Creation Date:
2025-12-26 @ 10:32 AM
Ignite Modification Date:
2026-02-03 @ 8:26 AM
Study NCT ID:
NCT05931328
Status:
RECRUITING
Last Update Posted:
2023-07-05
First Post:
2023-06-27
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
The Study of the Combination of Thiotepa and Pomalidomide for the Treatment of Relapsed/Refractory Primary Central Nervous System Lymphoma Patients.
Sponsor:
The First Affiliated Hospital with Nanjing Medical University
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Relapsed or Refractory (R/R) Primary Central Nervous System Lymphoma | View |
Keywords: